Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

250 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Predictive Factors of Response to Immunotherapy in Lymphomas: A Multicentre Clinical Data Warehouse Study (PRONOSTIM).
Detroit M, Collier M, Beeker N, Willems L, Decroocq J, Deau-Fischer B, Vignon M, Birsen R, Moufle F, Leclaire C, Balladur E, Deschamps P, Chauchet A, Batista R, Limat S, Treluyer JM, Ricard L, Stocker N, Hermine O, Choquet S, Morel V, Metz C, Bouscary D, Kroemer M, Zerbit J. Detroit M, et al. Among authors: deschamps p. Cancers (Basel). 2023 Aug 9;15(16):4028. doi: 10.3390/cancers15164028. Cancers (Basel). 2023. PMID: 37627056 Free PMC article.
Prognostic Value of FDG-PET/CT Parameters in Patients with Relapse/Refractory Multiple Myeloma before Anti-CD38 Based Therapy.
Fouquet G, Wartski M, Dechmi A, Willems L, Deau-Fischer B, Franchi P, Descroocq J, Deschamps P, Blanc-Autran E, Clerc J, Bouscary D, Barreau S, Chapuis N, Vignon M, Cottereau AS. Fouquet G, et al. Among authors: deschamps p. Cancers (Basel). 2021 Aug 27;13(17):4323. doi: 10.3390/cancers13174323. Cancers (Basel). 2021. PMID: 34503133 Free PMC article.
Pharmaceutical cancer care for haematology patients on oral anticancer drugs: Findings from an economic, clinical and organisational analysis.
Zerbit J, Kroemer M, Fuchs B, Detroit M, Decroocq J, Vignon M, Willems L, Deau-Fischer B, Franchi P, Deschamps P, Contejean A, Grignano E, Fouquet G, Birsen R, Mondesir J, Rocquet M, Huon JF, Batista R, Marty-Reboul J, Bouscary D. Zerbit J, et al. Among authors: deschamps p. Eur J Cancer Care (Engl). 2022 Nov;31(6):e13753. doi: 10.1111/ecc.13753. Epub 2022 Oct 23. Eur J Cancer Care (Engl). 2022. PMID: 36273820
Patients with Hematological Malignancies Treated with T-Cell or B-Cell Immunotherapy Remain at High Risk of Severe Forms of COVID-19 in the Omicron Era.
Zerbit J, Detroit M, Meyer A, Decroocq J, Deau-Fischer B, Deschamps P, Birsen R, Mondesir J, Franchi P, Miekoutima E, Guerin C, Batista R, Bouscary D, Willems L, Vignon M. Zerbit J, et al. Among authors: deschamps p. Viruses. 2022 Oct 27;14(11):2377. doi: 10.3390/v14112377. Viruses. 2022. PMID: 36366475 Free PMC article.
Anti-CD38 therapy impairs SARS-CoV-2 vaccine response against alpha and delta variants in patients with multiple myeloma.
Henriquez S, Zerbit J, Bruel T, Ouedrani A, Planas D, Deschamps P, Staropoli I, Hadjadj J, Varet B, Ermak N, Bouscary D, Willems L, Fouquet G, Decroocq J, Franchi P, Deau-Fischer B, Terrier B, Tamburini J, Chatenoud L, Schwartz O, Vignon M. Henriquez S, et al. Among authors: deschamps p. Blood. 2022 Feb 10;139(6):942-946. doi: 10.1182/blood.2021013714. Blood. 2022. PMID: 34905598 Free PMC article. No abstract available.
Subcutaneous azacitidine maintenance in transplantineligible patients with acute myeloid leukemia: a single-center retrospective study.
Johnson N, Templé M, Friedrich C, Willems L, Birsen R, Vignon M, Deschamps P, Franchi P, Mondesir J, Deau-Fischer B, Miekoutima E, Boussaid I, Chapuis N, Kosmider O, Bouscary D, Tamburini J, Decroocq J. Johnson N, et al. Among authors: deschamps p. Haematologica. 2023 Oct 1;108(10):2850-2854. doi: 10.3324/haematol.2022.282009. Haematologica. 2023. PMID: 36994502 Free PMC article. No abstract available.
Outcomes of refractory or relapsed Hodgkin lymphoma patients with post-autologous stem cell transplantation brentuximab vedotin maintenance: a French multicenter observational cohort study.
Marouf A, Cottereau AS, Kanoun S, Deschamps P, Meignan M, Franchi P, Sibon D, Antoine C, Gastinne T, Borel C, Hammoud M, Sicard G, Gille R, Cavalieri D, Stamatoullas A, Filliatre-Clement L, Lazarovici J, Chauchet A, Fornecker LM, Amorin S, Rocquet M, Raus N, Burroni B, Rubio MT, Bouscary D, Quittet P, Casasnovas RO, Brice P, Ghesquieres H, Tamburini J, Deau B. Marouf A, et al. Among authors: deschamps p. Haematologica. 2022 Jul 1;107(7):1681-1686. doi: 10.3324/haematol.2021.279564. Haematologica. 2022. PMID: 34965701 Free PMC article. No abstract available.
Pre-exposure prophylaxis with tixagevimab and cilgavimab (Evusheld) for COVID-19 among 1112 severely immunocompromised patients.
Nguyen Y, Flahault A, Chavarot N, Melenotte C, Cheminant M, Deschamps P, Carlier N, Lafont E, Thomas M, Flamarion E, Lebeaux D, Charlier C, Rachline A, Guérin C, Ratiney R, Touchard J, Péré H, Rozenberg F, Lanternier F, Arlet JB, Avouac J, Boussaud V, Guillemain R, Vignon M, Thervet E, Scemla A, Weiss L, Mouthon L; AP-HP-Centre Monoclonal Antibodies Working Group. Nguyen Y, et al. Among authors: deschamps p. Clin Microbiol Infect. 2022 Dec;28(12):1654.e1-1654.e4. doi: 10.1016/j.cmi.2022.07.015. Epub 2022 Aug 1. Clin Microbiol Infect. 2022. PMID: 35926762 Free PMC article.
Clinicopathological characterisation of myeloproliferative neoplasm-unclassifiable (MPN-U): a retrospective analysis from a large UK tertiary referral centre.
Deschamps P, Moonim M, Radia D, Curto-Garcia N, Woodley C, Bassiony S, O'Sullivan J, Harrington P, Raj K, Francis Y, Kordasti S, Ali S, Harrison CN, McLornan DP. Deschamps P, et al. Br J Haematol. 2021 May;193(4):792-797. doi: 10.1111/bjh.17375. Epub 2021 Mar 9. Br J Haematol. 2021. PMID: 33751548
250 results